Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for preparing human retina epithelial cell (ARPE) toxic model by utilizing amyloid protein A beta 25-35 and application of human retina epithelial cell (ARPE) toxic model

An amyloid and epithelial cell technology, applied in biochemical equipment and methods, animal cells, nervous system cells, etc., can solve the problems of inactivity, cumbersome preparation of oligomers, and inability to obtain ARPE cytotoxicity models. Easy-to-master, technically easy-to-use effects

Inactive Publication Date: 2017-06-13
GENERAL HOSPITAL OF PLA
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The purpose of the present invention is to provide a method for using amyloid Aβ25-35 to prepare human retinal epithelial cell (ARPE) toxicity model. Activity without access to the Aβ1-42-induced ARPE cytotoxicity model

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing human retina epithelial cell (ARPE) toxic model by utilizing amyloid protein A beta 25-35 and application of human retina epithelial cell (ARPE) toxic model
  • Method for preparing human retina epithelial cell (ARPE) toxic model by utilizing amyloid protein A beta 25-35 and application of human retina epithelial cell (ARPE) toxic model
  • Method for preparing human retina epithelial cell (ARPE) toxic model by utilizing amyloid protein A beta 25-35 and application of human retina epithelial cell (ARPE) toxic model

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Example 1: Preparation and detection of Aβ25-35 oligomer-induced ARPE cytotoxicity model

[0038] Use 0.25% trypsin-EDTA digestion solution to digest APRE cells in the proliferating phase, add 1ml digestion solution to a 10cm cell culture dish, digest for 2-5 minutes until the cells are in the shape of quicksand, add 1-2ml PRMI1640 complete medium (composition: 89% DMEM / F12 medium + 10% FBS + 1% double antibody) gently pipetting to single cells. After centrifuging at 1000rpm for 5 minutes, remove the supernatant, re-add PRMI1640 complete medium to make a single cell suspension, and inoculate into a 96-well cell culture plate, adjust the final cell seeding density to 15%, and the volume of each well is 100 μl.

[0039] After the inoculated cells were completely attached to the wall for 12 hours, the medium was discarded, and the culture medium containing different concentrations of Aβ25-35 oligomers (0 μmol / L, 0.3 μmol / L, 1.0 μmol / L, 5.0 μmol / L, 20 μmol / L, 60 μmol / L L) ...

Embodiment 2

[0041] Example 2: Detection of cell cycle-related genes in the ARPE cytotoxicity model induced by Aβ25-35 oligomers

[0042] ARPE cells were inoculated on 6cm cell culture dishes respectively, and Aβ25-35 oligomers were added to induce ARPE cytotoxicity model according to the treatment of cell inoculation and optimal concentration conditions (60 μmol / L) in Example 1, without adding Aβ25-35 oligomers Somatic cells were used as controls.

[0043] After Aβ25-35 oligomers treated ARPE cells for 48 hours, both cells were collected and total RNA was extracted (3 wells of cells in each group were repeated), and after reverse transcription, Q-PCR technology was used to analyze the relevant cell cycle in the cells. The specific gene CCNEmRNA expression, specific primer information is shown in Table 1. The ANOVA program in the SASV8 statistical software was used to test the difference of data by T-test, and the results were expressed as mean ± standard error, with P<0.05 as the standar...

Embodiment 3

[0047] Example 3: Activity detection of apoptosis-related key proteins in the ARPE cytotoxicity model induced by Aβ25-35 oligomers

[0048] ARPE cells were inoculated on 6cm cell culture dishes respectively, and Aβ25-35 oligomers were added to induce ARPE cytotoxicity model according to the treatment of cell inoculation and optimal concentration conditions (60 μmol / L) in Example 1, without adding Aβ25-35 oligomers Somatic cells were used as controls.

[0049] After Aβ25-35 oligomers treated ARPE cells for 48 hours, the two kinds of cells were collected and the total cell protein was extracted (3 wells of each group were repeated), and Western blotting technology and specific CASP3 antibody were used to analyze the protein prepared by this method. Changes in the activity of the key control protein CASP3 of apoptosis in an Aβ25-35 oligomer-induced ARPE cytotoxicity model.

[0050] The detection found that compared with the control cells without addition, the activity of CASP3 w...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for preparing a human retina epithelial cell (ARPE) toxic model by utilizing amyloid protein A beta 25-35 and application of a human retina epithelial cell (ARPE) toxic model. The method comprises the following steps: preparing an A beta 25-35 into oligomer by a cell culture medium; inoculating the cell and culturing; treating ARPE cell according to the A beta 25-35 oligomer in different concentrations; detecting cell number according to a MTT method. According to the method provided by the invention, the toxicity of A beta protein to ARPE cell is utilized to establish a cell toxic model; the cell toxic model can be applied to the in vitro accurate targeting research on the influence of the A beta protein on the age-related macular degeneration (AMD); a feasible effective research tool can be supplied for analyzing and revealing the inducing factor for the happening of the age-related macular degeneration (AMD) and a molecular regulation mechanism thereof.

Description

technical field [0001] The invention relates to the field of cytology, in particular to a method and application of using amyloid Aβ25-35 to prepare a human retinal epithelial cell (ARPE) toxicity model. Background technique [0002] Age-related macular degeneration (AMD) is one of the most common causes of vision loss or even loss in the elderly. With the growth of population aging, the incidence rate is increasing year by year, and the number of blind people caused by AMD accounts for 8.7% of the total number of blind people in the world. Seriously affect people's quality of life and survival safety. The most important morphological feature of AMD is drusen, the excessive deposition of abnormal metabolites of RPE cells. The composition of drusen is very complex and rich, which contains a variety of lipids and protein substances related to inflammation and oxidative stress, immune-related proteins, vitronectin, amyloid, complement regulatory molecules, etc. [0003] The ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/079C12Q1/02
CPCC12N5/0621G01N33/5014G01N33/5058
Inventor 叶子李朝辉
Owner GENERAL HOSPITAL OF PLA